Inpatient Care of Patients With Difficult to Treat Anorexia Nervosa - Factors Affecting Treatment Outcome.

January 9, 2026 updated by: Region Skane

Inpatient Care of Patients With Difficult to Treat Eating Disorders - What Affects Treatment Outcome?

The overall aim of the project is to investigate factors that may influence treatment outcomes in people with difficult-to-treat anorexia nervosa who are enrolled in inpatient care at the Region Skåne Eating Disorders Centre in Lund. Treatment expectations, sense of autonomy, and patient participation, will be investigated, as well as caregivers' attitudes towards, and experiences of working with, autonomy and patient participation in the inpatient setting. The research project is expected to contribute to increased knowledge about the treatment of difficult-to-treat anorexia nervosa, and what part patient participation and autonomy may play when treating severe eating disorders. The overall objectives of the research program are:

  1. To contribute to increased knowledge about factors that influence the treatment of people with difficult-to-treat anorexia nervosa
  2. To highlight the role of autonomy and patient participation in inpatient care of severe eating disorders
  3. To use the research results for clinical improvement work at Region Skåne Eating Disorders Center

Study Overview

Status

Not yet recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Individuals with anorexia nervosa admitted to inpatient care at Region Skåne Eating Disorders Center, a specialized psychiatric care unit for treatment of eating disorders.

Description

Inclusion Criteria:

  • Anorexia Nervosa diagnosis (ICD F50.0)
  • Admitted to inpatient care at department 5 at Region Skåne Eating Disorders Center

Exclusion Criteria:

  • Confidential identity
  • Inability to read or write in Swedish or English
  • Condition or treatment that, according to the study team, makes participation in the study inappropriate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body Mass Index (BMI)
Time Frame: BMI will be calulated on a weekly basis throughout the inpatient treatment period, and baseline measures until end of treatment/discharge from inpatient unit at approximately 12 weeks will be used for analysis.
BMI is calculated using weight and height: weight (kg) / (height (m) x height (m))
BMI will be calulated on a weekly basis throughout the inpatient treatment period, and baseline measures until end of treatment/discharge from inpatient unit at approximately 12 weeks will be used for analysis.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Treatment satisfaction
Time Frame: CSQ-8 is collected at the end of treatment/at discharge from inpatient care at approximately 12 weeks as well at 1 year follow-up after discharge, in order to evaluate the treatment given.
Satisfaction with treatment will be measured using the Client Satisfaction Questionnaire (CSQ-8), which contains 8 items. Total scores range from 8 to 32, with higher scores indicating greater satisfaction.
CSQ-8 is collected at the end of treatment/at discharge from inpatient care at approximately 12 weeks as well at 1 year follow-up after discharge, in order to evaluate the treatment given.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Region Skane

Investigators

  • Principal Investigator: Emelia Mellergård, PhD, Region Skåne VO Vuxenpsykiatri Lund

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 1, 2026

Primary Completion (Estimated)

December 1, 2028

Study Completion (Estimated)

December 1, 2029

Study Registration Dates

First Submitted

December 19, 2025

First Submitted That Met QC Criteria

January 9, 2026

First Posted (Actual)

January 20, 2026

Study Record Updates

Last Update Posted (Actual)

January 20, 2026

Last Update Submitted That Met QC Criteria

January 9, 2026

Last Verified

October 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2024-07313-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anorexia Nervosa

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe